The global sodium iodide market size will reach a valuation of USD 173 million in 2024, attributed to factors such as shift ...

With the CSF-1R inhibitor space heating up, Merck KGaA has gone all-in on pimicotinib, paying Abbisko Therapeutics $85 million to secure the global license to the drug. The German pharma ...

Bernstein analyst Florent Cespedes maintained a Hold rating on Merck KGaA (0O14 – Research Report) today and set a price target of €168.00. The company’s shares closed yesterday at €116.00.

This integration builds trust in AI systems regarding data authenticity and origin,” said Thomas Endress, Head of M-Trust™, Merck KGaA, Darmstadt, Germany. “Our collaboration with Zebra ...

(RTTNews) - Zebra Technologies Corporation (ZBRA) and Merck KGaA have collaborated to tackle challenges in product verification, authenticity, and trust. The partnership will introduce M-Trust ...

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...

Merck KGaA is doubling down on AI through a new collaboration agreement with tech firm Iktos, using its generative modelling technology to speed up the discovery and design of promising new compounds.

Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitising and automating frontline workflows, and Merck KGaA, Darmstadt, Germany, a leading science and technology company ...